Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q4 2017 (Next →)

Filing Date: Feb 13, 2018

Total Value: $136M (100.0% shares, 0.0% debt)

Holdings (29)

ALLERGAN PLC 11.8%
Value $16.03M Shares 98,000 Est. Cost $163.58 Unrealized
MGNX MACROGENICS INC 8.5%
Value $11.55M Shares 607,696 Est. Cost $18.67 Unrealized 0.0%
CIDARA THERAPEUTICS INC 8.2%
Value $11.21M Shares 1,647,879 Est. Cost $6.80 Unrealized
EIGER BIOPHARMACEUTICALS INC 7.0%
Value $9.469M Shares 678,793 Est. Cost $13.95 Unrealized
SBRA SABRA HEALTH CARE REIT INC 5.6%
Value $7.547M Shares 402,057 Est. Cost $18.77 Unrealized
CNC CENTENE CORP DEL 5.3%
Value $7.162M Shares 71,000 Est. Cost $48.44 Unrealized 0.0%
CHIMERIX INC 5.0%
Value $6.846M Shares 1,478,519 Est. Cost $4.63 Unrealized
ACHAOGEN INC 4.5%
Value $6.132M Shares 570,920 Est. Cost $10.74 Unrealized
QURE UNIQURE NV 4.1%
Value $5.578M Shares 284,717 Est. Cost $15.23 Unrealized 0.0%
ALMOST FAMILY INC 3.7%
Value $5.012M Shares 90,548 Est. Cost $55.35 Unrealized
REATA PHARMACEUTICALS INC 3.6%
Value $4.896M Shares 172,897 Est. Cost $28.32 Unrealized
QUOTIENT LTD 3.4%
Value $4.616M Shares 932,523 Est. Cost $4.95 Unrealized
IGNYTA INC 3.4%
Value $4.575M Shares 171,352 Est. Cost $26.70 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 3.0%
Value $4.055M Shares 506,852 Est. Cost $8.03 Unrealized 0.0%
ENDOLOGIX INC 2.6%
Value $3.509M Shares 655,815 Est. Cost $5.35 Unrealized
RADIUS HEALTH INC 2.6%
Value $3.495M Shares 110,000 Est. Cost $31.77 Unrealized
PARATEK PHARMACEUTICALS INC 2.3%
Value $3.194M Shares 178,453 Est. Cost $17.90 Unrealized
AVEO PHARMACEUTICALS INC 2.2%
Value $2.951M Shares 1,057,690 Est. Cost $2.79 Unrealized
NABRIVA THERAPEUTICS PLC 2.2%
Value $2.939M Shares 491,395 Est. Cost $5.98 Unrealized
CLOVIS ONCOLOGY INC 2.0%
Value $2.72M Shares 40,000 Est. Cost $68.00 Unrealized
BELLICUM PHARMACEUTICALS INC 1.9%
Value $2.534M Shares 301,349 Est. Cost $8.41 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL IN 1.5%
Value $2.069M Shares 44,600 Est. Cost $49.03 Unrealized 0.0%
DXCM DEXCOM INC 1.3%
Value $1.79M Shares 31,198 Est. Cost $13.00 Unrealized 0.0%
ON ASSIGNMENT INC 1.2%
Value $1.652M Shares 25,700 Est. Cost Unrealized
LIPOCINE INC NEW 0.9%
Value $1.283M Shares 373,101 Est. Cost $3.44 Unrealized
CONFORMIS INC 0.7%
Value $952K Shares 400,000 Est. Cost $2.38 Unrealized
NOVELION THERAPEUTICS INC 0.7%
Value $925K Shares 296,488 Est. Cost $3.12 Unrealized
ACHC ACADIA HEALTHCARE COMPANY IN 0.6%
Value $878K Shares 26,916 Est. Cost $34.65 Unrealized 0.0%
ADAMAS PHARMACEUTICALS INC 0.3%
Value $407K Shares 12,000 Est. Cost $33.92 Unrealized